Article (Scientific journals)
Changes in the management and comorbidities of acromegaly over three decades. The French Acromegaly Registry.
Maione, Luigi; Brue, Thierry; Beckers, Albert et al.
2017In European Journal of Endocrinology, 176 (5), p. 645-655
Peer Reviewed verified by ORBi
 

Files


Full Text
EJE-Maione2017.pdf
Publisher postprint (1.27 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] CONTEXT: Acromegaly is a rare disease associated with chronic multisystem complications. National registries have been created in several countries. DESIGN: The French registry contains data on acromegaly epidemiology, management and comorbidities recorded over more than three decades, retrospectively until 1999 and prospectively from 1999 until 2012. RESULTS: Data could be analyzed for 999 of the 1034 patients included in the registry (46% males). Disease control, defined as IGF-I normalization (adjusted for age and sex), was achieved in 75% of patients at the last follow-up visit. Half the patients with uncontrolled disease had IGF-I levels below 1.5 times the upper limit of normal (ULN). The proportion of patients with surgically cured disease did not change markedly over time, whereas the proportion of patients with uncontrolled disease fell and the proportion of patients with medically controlled disease rose. Cardiovascular, metabolic, respiratory and rheumatologic comorbidities and their outcomes were recorded for most patients, and no noteworthy overall deterioration was noted over time. Cancer occurred in 10% of patients, for a standardized incidence ratio of 1.34 (95% CI, 0.94-1.87) in men and 1.24 (0.77-1.73) in women. Forty-one patients died during follow-up, for a standardized mortality ratio of 1.05 (0.70-1.42). Most deaths were due to cancer. CONCLUSIONS: The majority of patients with acromegaly now have successful disease control thanks to multistep management. The incidence of comorbidities following diagnosis of acromegaly is very low. Life expectancy is now close to that of the general population, probably owing to better management of the GH/IGF-I excess and comorbidities.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Maione, Luigi
Brue, Thierry
Beckers, Albert ;  Université de Liège > Département des sciences cliniques > Endocrinologie
Delemer, Brigitte
PETROSSIANS, Patrick  ;  Centre Hospitalier Universitaire de Liège - CHU > Service d'endocrinologie clinique
Borson-Chazot, Francoise
Chabre, Olivier
Francois, Patrick
Bertherat, Jerome
Cortet, Christine
Chanson, Philippe
Language :
English
Title :
Changes in the management and comorbidities of acromegaly over three decades. The French Acromegaly Registry.
Publication date :
2017
Journal title :
European Journal of Endocrinology
ISSN :
0804-4643
eISSN :
1479-683X
Publisher :
BioScientifica, United Kingdom
Volume :
176
Issue :
5
Pages :
645-655
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 04 May 2017

Statistics


Number of views
74 (7 by ULiège)
Number of downloads
4 (4 by ULiège)

Scopus citations®
 
127
Scopus citations®
without self-citations
106
OpenCitations
 
83

Bibliography


Similar publications



Contact ORBi